Trial Details

RECRUITING
Basic Information
Clinical ID c895
Identifier NCT05867329
Trial Title A Trial for Acute Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis Acute
Interventions DRUG: Cyclosporine Injection (IV)|DRUG: Cyclosporine Oral Product|DRUG: Upadacitinib Extended Release Oral Tablet|DRUG: Intravenous Methylprednisolone|DRUG: Prednisone Oral Product
Participant Information
Sponsor Berinstein, Jeffrey
City Ann Arbor
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2023-09-30 00:00:00.000000
Primary Completion Date 2025-05-26 00:00:00.000000
Completion Date 2025-05-26 00:00:00.000000